相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。SRC Signaling Is Crucial in the Growth of Synovial Sarcoma Cells
Sebastian Michels et al.
CANCER RESEARCH (2013)
Reversible Disruption of mSWI/SNF (BAF) Complexes by the SS18-SSX Oncogenic Fusion in Synovial Sarcoma
Cigall Kadoch et al.
CELL (2013)
High-Throughput Selectivity Assays for Small-Molecule Inhibitors of β-Catenin/T-Cell Factor Protein-Protein Interactions
Min Zhang et al.
ACS MEDICINAL CHEMISTRY LETTERS (2013)
WNT signalling pathways as therapeutic targets in cancer
Jamie N. Anastas et al.
NATURE REVIEWS CANCER (2013)
Genome-wide recruitment to Polycomb-modified chromatin and activity regulation of the synovial sarcoma oncogene SYT-SSX2
Christina B. Garcia et al.
BMC GENOMICS (2012)
Deconstruction of the SS18-SSX Fusion Oncoprotein Complex: Insights into Disease Etiology and Therapeutics
Le Su et al.
CANCER CELL (2012)
Wnt/β-Catenin Signaling and Disease
Hans Clevers et al.
CELL (2012)
High-Frequency Canonical Wnt Activation in Multiple Sarcoma Subtypes Drives Proliferation through a TCF/β-Catenin Target Gene, CDC25A
Sapna Vijayakumar et al.
CANCER CELL (2011)
Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy
Jordi Barretina et al.
NATURE GENETICS (2010)
CK1ε Is Required for Breast Cancers Dependent on β-Catenin Activity
So Young Kim et al.
PLOS ONE (2010)
Small Molecule Inhibitors of Wnt/β-Catenin/Lef-1 Signaling Induces Apoptosis in Chronic Lymphocytic Leukemia Cells In Vitro and In Vivo
Rajesh Kumar Gandhirajan et al.
NEOPLASIA (2010)
A CreER-Based Random Induction Strategy for Modeling Translocation-Associated Sarcomas in Mice
Malay Haldar et al.
CANCER RESEARCH (2009)
Histone deacetylase inhibitors reverse SS18-SSX-mediated polycomb silencing of the tumor suppressor early growth response 1 in synovial sarcoma
Joanna M. Lubieniecka et al.
CANCER RESEARCH (2008)
Synovial sarcoma: From genetics to genetic-based animal modeling
Malay Haldar et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2008)
The molecular mechanism governing the oncogenic potential of SOX2 in breast cancer
Yupeng Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Insulin-like growth factor-I receptor acts as a growth regulator in synovial sarcoma
N. Friedrichs et al.
JOURNAL OF PATHOLOGY (2008)
Wnt signalling and its impact on development and cancer
Alexandra Klaus et al.
NATURE REVIEWS CANCER (2008)
A conditional mouse model of synovial sarcoma: Insights into a myogenic origin
Malay Haldar et al.
CANCER CELL (2007)
Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas:: hypoxia-induced transcription profile signifies metastatic potential
Princy Francis et al.
BMC GENOMICS (2007)
Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel
George Z. Cheng et al.
CANCER RESEARCH (2007)
Mining the Wnt pathway for cancer therapeutics
Nick Barker et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
The synovial sarcoma-associated SS18-SSX2 fusion protein induces epigenetic gene (De)regulation
Diederik R. H. de Bruijn et al.
CANCER RESEARCH (2006)
Inhibition of protein-protein interactions:: The discovery of druglike β-catenin inhibitors by combining virtual and biophysical screening
JY Trosset et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2006)
The synovial sarcoma translocation protein SYT-SSX2 recruits β-catenin to the nucleus andassociates with it in an active complex
D. Pretto et al.
ONCOGENE (2006)
Pitfalls in the detection of t(11;22) translocation by fluorescence in situ hybridization and RT-PCR: A single-blinded study
N Friedrichs et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2006)
Phosphorylation of β-catenin by cyclic AMP-dependent protein kinase
S Taurin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Gene expression profiling of human sarcomas: Insights into sarcoma biology
K Baird et al.
CANCER RESEARCH (2005)
Functional correlates of mutation of the Asp32 and Gly34 residues of beta-catenin
E Provost et al.
ONCOGENE (2005)
Establishment and characterization of a biphasic synovial sarcoma cell line, SYO-1
A Kawai et al.
CANCER LETTERS (2004)
Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex
M Lepourcelet et al.
CANCER CELL (2004)
Classification and subtype prediction of adult soft tissue sarcoma by functional genomics
NH Segal et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Molecular characterisation of soft tissue tumours: a gene expression study
TO Nielsen et al.
LANCET (2002)
Control of β-catenin phosphorylation/degradation by a dual-kinase mechanism
CM Liu et al.
CELL (2002)
Analysis of transforming activity of human synovial sarcoma-associated chimeric protein SYT-SSX1 bound to chromatin remodeling factor hBRM/hSNF2α
M Nagai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Prognostic significance of histologic grade and nuclear expression of β-catenin in synovial sarcoma
T Hasegawa et al.
HUMAN PATHOLOGY (2001)
分享论文
